Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Hartung HP, Benedict RHB, Berger T, Bermel RA, et al. Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial. Neurology 2024;103:e210049.
PMID: 39626127


Privacy Policy